Fosun Pharma meldet Q1 2026: Nettogewinn der Aktionäre steigt um 21,96 % im Jahresvergleich, starke Pipeline-Umsetzung.

Quelle: PR Newswire
Link: https://www.prnewswire.com/news-releases/fosun-pharma-announces-q1-2026-results-net-profit-attributable-to-shareholders-after-deducting-non-recurring-gains-and-losses-increased-by-21-96-yoy-with-strong-pipeline-execution-302755880.html